Medicare spending on Ozempic and similar diabetes drugs soars, study finds, and it could end up costing seniors
By Tami Luhby, CNN (CNN) — Medicare shelled out $5.7 billion on Ozempic and other similar diabetes drugs in 2022, up from $57 million in 2018, according to a new KFF analysis. The pricey medications, which include Mounjaro and Rybelsus, have become super popular for the treatment of diabetes and for weight loss. But Medicare
Continue Reading